• Renal biomarkers and outcomes in outpatients with heart failure: The Atlanta cardiomyopathy consortium 

      Georgiopoulou V.V., Tang W.H.W., Giamouzis G., Li S., Deka A., Dunbar S.B., Butler J., Kalogeropoulos A.P. (2016)
      Background/objectives Cystatin-C and beta-2-microglobulin may be superior to serum creatinine, blood urea nitrogen (BUN), or estimated glomerular filtration rate (EGFR) in patients hospitalized with heart failure (HF). We ...
    • A revised international prognostic score system for Waldenström’s macroglobulinemia 

      Kastritis E., Morel P., Duhamel A., Gavriatopoulou M., Kyrtsonis M.C., Durot E., Symeonidis A., Laribi K., Hatjiharissi E., Ysebaert L., Vassou A., Giannakoulas N., Merlini G., Repousis P., Varettoni M., Michalis E., Hivert B., Michail M., Katodritou E., Terpos E., Leblond V., Dimopoulos M.A. (2019)
      A staging system was developed a decade ago for patients with Waldenström’s macroglobulinemia (WM), however, since then WM treatments have changed. A revised staging system could better capture prognosis of WM patients in ...